Grace Therapeutics, Inc. (GRCE)

Change in Working Capital

-$1.07M

Quarterly · Period ending: · USD

GRCE logo

GRCE Change in Working Capital

Latest reported-$1.07M
GRCE Quarterly Change in Working Capital (-$530.00K → -$1.07M)
High-resolution chart · PNG

GRCE change in working capital history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Grace Therapeutics, Inc. Change in Working Capital — Quarterly (USD)
Period endingChange in Working Capital (USD)
-1,071,000
1,002,653
-88,785
-983,501
770,000
-66,000
-695,000
202,000
901,000
704,000
506,000
-464,000
-2,026,000
353,000
-35,000
1,134,000
-1,271,000
1,032,000
-683,000
-2,602,000
-659,183
-712,291
-2,565,251
-2,918,015
-1,599,024
-289,401
-1,997,000
-1,244,000
293,000
1,540,761
-19,823
2,088,993
2,647,506
2,278,880
-322,067
1,072,122
331,395
-21,584
524,800
143,376
-422,336
269,219
-619,733
791,741
-414,350
-120,881
561,069
1,104,995
-3,393,481
669,797
1,406,918
322,816
1,381,494
475,191
-322,076
249,308
-429,732
-1,553,716
640,574
308,163
669,771
-660,974
190,692
201,993
97,249
-190,219
220,663
-530,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.